HOME >> MEDICINE >> NEWS
Exploring better ways to determine when to change the course of treatment

Counting circulating tumor cells before and after the start of treatment for patients with metastatic colorectal cancer could help doctors determine when or if a change in treatment should be made. The results of a large, multicenter, international study laying the groundwork for such decisions were presented today at the Annual Meeting of the American Society of Clinical Oncology. The study showed the number of circulating tumor cells, or CTC, is a significant predictor of survival and cancer progression.

Few studies have examined the relationship of CTC and a patient's prognosis in cancer. This is an important area of research in metastatic colorectal cancer because there are little data to help physicians chose which treatment is best for which patients or to determine when a change in treatment is warranted.

"If we had a way to know early on that a tumor isn't responding to a particular drug, we could switch to a different treatment before growth of the cancer is seen on a CAT scan," said Neal J. Meropol, director of the gastrointestinal cancer program at Fox Chase Cancer Center and lead investigator of the study. "If we could determine that the tumor was destined to grow after a few weeks of treatment, we'd be able alter course even before the first scan."

For this study, Meropol and his colleagues examined the association between the circulating tumor cell number and progression-free and overall survival for 430 adult patients with metastatic colorectal cancer.

The number of CTC was measured at baseline, one month, and several other points after the start of treatment. CTC were isolated and counted by an immunomagnetic cell separation technique, an FDA-approved technology developed by Immunicon Corporation (Nasdaq-Global Market: IMMC}. CT scans were obtained in usual practiceat baseline and every 6-12 weeks after starting treatment.

Having 3 or more CTC (per 7.5 mL of blood) was defined as "unfavo
'"/>

Contact: Karen Mallet
karen.mallet@fccc.edu
215-728-9751
Fox Chase Cancer Center
3-Jun-2007


Page: 1 2

Related medicine news :

1. Exploring the molecular origin of blood clot flexibility
2. Exploring the potential of cholesterol-lowering drugs for patients with systemic sclerosis
3. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
4. Waist-to-hip ratio may better predict cardiovascular risk than body mass index
5. Warfarin better than aspirin at stroke prevention in elderly people with atrial fibrillation
6. Nonsmall cell lung cancer -- chemotherapy before surgery appears better than surgery alone
7. Stroke in nonvascular atrial fibrillation -- anti-coagulants better than anti-platelet therapy
8. Holograms make for better vision tests
9. Parents of chronically ill kids are helped by better access to federal and employer leave
10. Diabetes professionals join forces to identify gaps in diabetes care and better self care
11. Gene variations point to why lung cancer drugs work better in Japanese vs. US patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2019)... ... April 18, 2019 , ... It's time to try a ... Get to the root of the matter before those pesky dandruff flakes reach ... , Now you can attack dandruff before it attacks you. New Don’t ...
(Date:4/18/2019)... ... April 18, 2019 , ... Catalent, a global ... the upcoming Global Clinical Supplies Group (GCSG) 2019 US Annual Conference at the ... – May 1, 2019. , Erin Vlack, Project Manager, will present a workshop ...
(Date:4/18/2019)... ... April 18, 2019 , ... Dr. Matt Nejad is ... a full menu of cosmetic and general dental care services. Dr. Nejad is ... which relies on minimally-invasive techniques in restorative dentistry. Biomimetic dentistry uses a more ...
(Date:4/17/2019)... Fla. (PRWEB) , ... April 17, 2019 , ... With ... headlines, scientists are working to curb the death toll by looking for an alternative ... Spring 2019 National Meeting & Exposition this week. , Naloxone (often known by the ...
(Date:4/17/2019)... ... April 17, 2019 , ... ... reduce hangover symptoms. This California-made supplement was designed to lessen the negative ... now available for purchase via GotPurpleTree.com and Amazon.com . , ...
Breaking Medicine News(10 mins):
(Date:4/18/2019)... ... April 18, 2019 , ... ... of its industry-leading OPTIMASE® portfolio of biobased enzymes for medical instrument cleaning ... needs and specific challenges faced by medical instrument cleaning customers,” said Sheril ...
(Date:4/17/2019)... ATLANTA, Ga. (PRWEB) , ... April 17, 2019 ... ... solutions to healthcare providers and patients, announced today it has completed the acquisition ... Founded in 2012, Omni Holdings is the leading medical lien funding company operating ...
(Date:4/17/2019)... ... , ... Lillibridge Healthcare Services Inc., a wholly owned subsidiary ... of medical office buildings (MOBs), will sponsor and host three educational sessions featuring ... Association (BOMA) International Medical Office Buildings + Healthcare Facilities Conference May 1-3 in ...
Breaking Medicine Technology:
Cached News: